Skip to content
Search AI Powered

Latest Stories

Heart surgeon 'turned down' training on pioneering robot he used in operation where patient died

heart surgeon reportedly turned down the chance to train on a robot he used in an operation in which the patient later died.

Stephen Pettitt, 69, suffered multiple organ failure and died days after the procedure at the Freeman Hospital in Newcastle in March 2015.


Pettitt's heart valve operation was assisted by a robot and it was the first of its type at the trust.

On 4 November a coroner was told that the lead surgeon, Sukumaran Nair, reportedly admitted to a colleague that he could undergo more training on the sophisticated system. The robotics experts who were assisting the surgical team left part-way through the operation without informing staff.

Although robots such as the Da Vinci system are used to enable accurate key-hole surgery, the surgery in 2015, which was done to repair a mitral valve, damaged the interatrial septum, forcing the team to open Pettitt’s chest to repair the tear, reports indicate.

"By that time the operation had been going on for a considerable period of time," pathologist Nigel Cooper was quoted as saying by the Telegraph. “By the end of the surgery, the heart was functioning very poorly."

Although attempts were made to improve the heart function, Pettitt's organs began to shut down and he could not recover.

After the patient died, Nair telephoned Paul Renforth, a co-ordinator in the use of robotics at the Freeman Hospital, to say "the procedure had not gone as planned."

Renforth added: "(He said) possibly he could have done some more dry-run training."

The co-ordinator also said that the atmosphere in the operating room was tense.

The five-day inquest, which was attended by Pettitt’s sister and daughter, continues

More For You

Priya Kaul: Finding hope in the face of difficulties

Priya Kaul

Priya Kaul: Finding hope in the face of difficulties

Asjad Nazir

DR PRIYA KAUL discovered her connection to unseen energies as a child and always felt drawn to helping others.

This early enlightenment, combined with personal challenges, led her to a spiritual path of self-healing and empowering others. Today, as a respected spiritual life coach and healer, she helps people reconnect with their inner strength, heal themselves, and re-invent their relationship with life. Using a variety of techniques, she views her work as a calling rather than a career.

Keep ReadingShow less
Manisha-Koirala-Ovacome

Ovacome’s CEO, Victoria Clare, welcomed Koirala’s appointment, highlighting the impact her advocacy could have

Manisha Koirala joins UK cancer charity Ovacome as ambassador

BOLLYWOOD actor Manisha Koirala has been announced as the new ambassador for Ovacome, the UK-based ovarian cancer support charity.

Koirala, who overcame stage 4 ovarian cancer nearly a decade ago, will work with the organisation to support patients, promote early detection, and address health inequalities.

Keep ReadingShow less
brain-structures-at-birth-getty

Researchers from the University of Cambridge, UK, examined brain scans of over 500 newborns—236 girls and 278 boys—aged between 0 and 28 days. (Representational image: iStock)

Girls have more grey matter, boys more white matter at birth: Study

A NEW study has found that newborn girls and boys have distinct brain structures at birth. While boys tend to have larger brains with more white matter, girls have significantly more grey matter, which is linked to learning, speech, and cognition.

Published in the journal Biology of Sex Differences, the study suggests these differences may result from biological sex-specific development in the womb.

Keep ReadingShow less
nhs-hospital-getty

NHS faces pressure as flu admissions rise sharply

FLU cases in the country have surged, with over 5,000 hospital admissions last week, marking a sharp increase as the NHS faces pressure from a winter quad-demic of flu, Covid, respiratory syncytial virus (RSV), and norovirus.

According to The Times, flu admissions rose from 4,102 on Christmas Day to 5,074 by 29 December.

Keep ReadingShow less
AI-diabetes-risk-tool-iStock

World's first AI diabetes risk tool to be tested by NHS in 2025

THE NHS in England is set to launch a world-first trial of an artificial intelligence (AI) tool that predicts the risk of developing type 2 diabetes up to 13 years before symptoms appear.

The trial, scheduled for 2025, will take place at Imperial College Healthcare NHS Trust and Chelsea and Westminster Hospital NHS Foundation Trust, The Guardian reported.

Keep ReadingShow less